Stabilized collagen scaffolds for heart valve tissue engineering

Tissue Engineering - Part A

Volumn 15, Issue 6, 2009, Pages 1257-1268

  Tedder, Mary E ^a   Liao, Jun ^b   Weed, Benjamin ^b   Stabler, Christopher ^a   Zhang, Henry ^a   Simionescu, Agneta ^a   Simionescu, Dan T ^a  

^a AMRL   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADATION; BIOMECHANICS; CELL CULTURE; COLLAGEN; CROSSLINKING; FIBROBLASTS; GLUCOSE; MECHANICAL PROPERTIES; SEEPAGE; SOIL MECHANICS; TISSUE; TISSUE ENGINEERING;

BIAXIAL MECHANICAL PROPERTIES; CELL INFILTRATION; COLLAGEN SCAFFOLDS; COLLAGENASE; DECELLULARIZATION; DECELLULARIZED; GLUTARALDEHYDE; GLUTARALDEHYDE CROSS-LINKING; HEART VALVES; IN-VIVO; MATRIX REMODELING; PARTIAL STABILIZATION; POLYPHENOL; TISSUE REMODELING;

SCAFFOLDS;

COLLAGEN; COLLAGENASE; GLUCOSE PENTAGALLATE; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HEART VALVE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; TISSUE ENGINEERING;

RATTUS; SUS;

EID: 66249110672     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0263     Document Type: Article

References (46)

1. Yacoub M. Viewpoint: heart valve engineering. Interview by James Butcher. Circulation 116, f44, 2007.
2. Schoen FJ. New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, February 12, 2006. Cardiovasc Pathol 15, 271, 2006.
3. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34, 1799, 2006.
4. Simionescu D, Simionescu A, Deac R. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves. J Biomed Mater Res 27, 697, 1993.
5. Simionescu D, Iozzo RV, Kefalides NA. Bovine pericardial proteoglycan: biochemical, immunochemical and ultrastructural studies. Matrix 9, 301, 1989.
6. Simionescu DT, Kefalides NA. The biosynthesis of proteoglycans and interstitial collagens by bovine pericardial fibroblasts. Exp Cell Res 195, 171, 1991.
7. Liao J, Yang L, Grashow J, Sacks MS. Molecular orientation of collagen in intact planar connective tissues under biaxial stretch. Acta Biomater 1, 45, 2005.
8. Obermiller JF, Hodde JP, McAlexander CS, Kokini K, Badylak SF. A comparison of suture retention strengths for three biomaterials. Med Sci Monit 10, PI1, 2004.
9. Oswal D, Korossis S, Mirsadraee S, Wilcox H, Watterson K, Fisher J, Ingham E. Biomechanical characterization of decellularized and cross-linked bovine pericardium. J Heart Valve Dis 16, 165, 2007.
10. Moazami N, Bessler M, Argenziano M, Choudhri AF, Cabreriza SE, Allendorf JD, Rose EA, Oz MC. Transluminal aortic valve placement. A feasibility study with a newly designed collapsible aortic valve. Asaio J 42, M381, 1996.
11. Deac RF, Simionescu D, Deac D. New evolution in mitral physiology and surgery: mitral stentless pericardial valve. Ann Thorac Surg 60, S433, 1995.
12. Mirsadraee S, Wilcox HE, Watterson KG, Kearney JN, Hunt J, Fisher J, Ingham E. Biocompatibility of acellular human pericardium. J Surg Res 143, 407, 2007.
13. Raghavan D, Simionescu DT, Vyavahare NR. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials 28, 2861, 2007.
14. Billiar KL, Sacks MS. Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp - Part I: experimental results. J Biomech Eng 122, 23, 2000.
15. Wells SM, Sacks MS. Effects of fixation pressure on the biaxial mechanical behavior of porcine bioprosthetic heart valves with long-term cyclic loading. Biomaterials 23, 2389, 2002.
16. Grashow JS, Yoganathan AP, Sacks MS. Biaixal stress-stretch behavior of the mitral valve anterior leaflet at physiologic strain rates. Ann Biomed Eng 34, 315, 2006.
17. Simionescu D, Iozzo RV, Kefalides NA. Bovine pericardial proteoglycan: biochemical, immunochemical and ultrastructural studies. Matrix 9, 301, 1989.
18. Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis 12, 226, 2003.
19. Isenburg JC, Simionescu DT, Starcher BC, Vyavahare NR. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115, 1729, 2007.
20. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A 66, 93, 2003.
21. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 52, 523, 1985.
22. Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol 13, 146, 2004.
23. Simionescu A, Simionescu D, Deac R. Lysine-enhanced glutaraldehyde crosslinking of collagenous biomaterials. J Biomed Mater Res 25, 1495, 1991.
24. Tang HR, Covington AD, Hancock RA. Structure-activity relationships in the hydrophobic interactions of polyphenols with cellulose and collagen. Biopolymers 70, 403, 2003.
25. Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials 26, 1237, 2005.
26. Kasyanov V, Isenburg J, Draughn RA, Hazard S, Hodde J, Ozolanta I, Murovska M, Halkes SB, Vrasidas I, Liskamp RM, Pieters RJ, Simionescu D, Markwald RR, Mironov V. Tannic acid mimicking dendrimers as small intestine sub-mucosa stabilizing nanomordants. Biomaterials 27, 745, 2006.
27. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 29, 1065, 2008.
28. Stella JA, Liao J, Sacks MS. Time-dependent biaxial mechanical behavior of the aortic heart valve leaflet. J Biomech 40, 3169, 2007.
29. Simionescu DT, Lu Q, Song Y, Lee JS, Rosenbalm TN, Kelley C, Vyavahare NR. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials 27, 702, 2006.
30. Simionescu A, Simionescu D, Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. Asaio J 42, M561, 1996.
31. Simionescu DT. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther 4, 1971, 2004.
32. Simionescu DT, Lovekamp JJ, Vyavahare NR. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A 66, 755, 2003.
33. Meuris B, Phillips R, Moore MA, Flameng W. Porcine stentless bioprostheses: prevention of aortic wall calcification by dye-mediated photo-oxidation. Artif Organs 27, 537, 2003.
34. Simpson CL, Lindley S, Eisenberg C, Basalyga DM, Starcher BC, Simionescu DT, Vyavahare NR. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol 16, 29, 2007.
35. Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 27, 1507, 2006.
36. Simionescu DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 12, 217, 2003.
37. Shi B, He XQ, Haslam E. Gelatin-polyphenol interaction. J Am Leather Chem As 89, 98, 1994.
38. Charlton AJ, Baxter NJ, Lilley TH, Haslam E, McDonald CJ, Williamson MP. Tannin interactions with a full-length human salivary proline-rich protein display a stronger affinity than with single proline-rich repeats. Febs Lett 382, 289, 1996.
39. Luck G, Liao H, Murray NJ, Grimmer HR, Warminski EE, Williamson MP, Lilley TH, Haslam E. Polyphenols, astringency and proline-rich proteins. Phytochemistry 37, 357, 1994.
40. Haslam E. Plant Polyphenols: Vegetable Tannins Revisited. Cambridge, UK: Cambridge University Press, 1989.
41. Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 27, 3645, 2006.
42. Zilla P, Brink J, Human P, Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials 29, 385, 2008.
43. Robinson PS, Johnson SL, Evans MC, Barocas VH, Tranquillo RT. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng 14, 83, 2008.
44. Migneco F, Hollister SJ, Birla RK. Tissue-engineered heart valve prostheses: 'state of the heart'. Regen Med 3, 399, 2008.
45. Knight RL, Wilcox HE, Korossis SA, Fisher J, Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng [H] 222, 129, 2008.
46. di Marco F, Gerosa G. Heart valve tissue engineering: research should proceed along validated routes. J Thorac Cardiovasc Surg 135, 1406, 2008.